Author response for 'Variability in eGFR and the risk of major clinical outcomes in diabetes: post‐hoc analysis from the ADVANCE trial'

Autor:	null M Jun, null K Harris, null HJL Heerspink, null SV Badve, null MJJ Jardine, null S Harrap, null P Hamet, null M Marre, null N Poulter, null S Kotwal, null M Gallagher, null V Perkovic, null J Chalmers, null M Woodward, null the ADVANCE Collaborative Group
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry Diabetes mellitus Post-hoc analysis medicine medicine.disease business Intensive care medicine
DOI:	10.1111/dom.14351/v2/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a4b2923e4567624656bfdfd5013063e5 https://doi.org/10.1111/dom.14351/v2/response1 Zobrazit plný text záznamu